Imugene (ASX:IMU) Share Price and News - StockTrack

Market Cap (3-Jul) $3,153,122 (199th)	Close (30-Jun) $0.091 0 (0%)	Volume (30-Jun) 50,159,971	Shortsold (19-Jun) 392,315,164 (5.25%) (41st)
52w High $2.75	52w Low $0.340	P/E -	EPS -0.6

	Subject
	IMU IMU Ann: Imugene to Present HER-Vaxx Phase 2 Data at AACR21 Meeting
	1 (current) 2 3
	IMU IMU Ann: Half Yearly Report and Accounts
	IMU IMU Ann: Appendix 2A
	IMU IMU Ann: Proposed issue of Securities - IMU
	IMU IMU Ann: Imugene Commences Cohort 2 Dosing in Phase 1 PD1-VAXX Trial
	IMU IMU Ann: Appendix 2A
	IMU IMU Ann: Proposed issue of Securities - IMU
	IMU IMU Ann: Appendix 4C - quarterly
	IMU IMU Ann: Appendix 2A
	IMU IMU Ann: Proposed issue of Securities - IMU
	IMU IMU Ann: Imugene Dose Escalates in PD1-VAXX Phase 1 Clinical Trial
	IMU IMU Ann: IMUGENE COMPLETES RECRUITMENT TO HER-VAXX PHASE 2 TRIALIM
	IMU IMU Ann: Change of Director's Interest Notice - LC
	IMU IMU Ann: Change of Director's Interest Notice - PH
	IMU IMU Ann: Appendix 2A
	IMU IMU Ann: Proposed issue of Securities - IMU
	IMU IMU Ann: Change of Director's Interest Notice - AH
	IMU IMU Ann: Imugene Enrols First Cohort of PD1-Vaxx Clinical Trial
	IMU IMU Ann: Appendix 3G
	IMU IMU Ann: Appendix 2A
	IMU IMU Ann: Proposed issue of Securities - IMU
	IMU IMU Ann: Changes to Executive Chairman Remuneration
	IMU IMU Ann: Imugene Receives $4.82 million R&D Tax Incentive
	IMU IMU Ann: Appendix 2A and 708A Notice
	IMU IMU Ann: Proposed issue of Securities - IMU
	IMU IMU Ann: Change of Director's Interest Notice - CW
	IMU IMU Ann: Appendix 3G
	IMU IMU Ann: Appendix 2A
	IMU IMU Ann: Proposed issue of Securities - IMU
	IMU IMU Ann: Imugene First Patient Dosed in PD1-VAXX Clinical Trial
	IMU IMU Ann: Appendix 2A
	IMU IMU Ann: Appendix 2A
	IMU IMU Ann: Proposed issue of Securities - IMU
	IMU IMU Ann: Results of Meeting
	IMU IMU Ann: Investor Presentation
	IMU IMU Ann: AGM Presentation
	IMU IMU Ann: Imugene HER Vaxx shows positive Overall Survival in trial
	IMU IMU Ann: Release of Securities from Escrow
	IMU IMU Ann: Appendix 2A
	IMU IMU Ann: Proposed issue of Securities - IMU
	IMU IMU Ann: Proposed issue of Securities - IMU
	IMU IMU Ann: Appendix 2A
	IMU IMU Ann: Appendix 2A
	IMU IMU Ann: Proposed issue of Securities - IMU
	IMU IMU Ann: Becoming a substantial holder
	IMU IMU Ann: Letter to IMUOA Optionholders
	IMU IMU Ann: Imugene Receives FDA IND Approval for PD1-VAXX Trial in USA
	IMU IMU Ann: Appendix 4C - quarterly
	IMU IMU Ann: Appendix 2A
	IMU IMU Ann: Proposed issue of Securities - IMU

Similar Companies

CSL

Clinuvel Pharmaceuticals

CUV

Immutep

IMM

Mesoblast

MSB

Opthea

OPT

Paradigm Biopharmaceuticals

PAR

PYC Therapeutics

PYC

Race Oncology

RAC

Telix Pharmaceuticals

TLX

End of Day Prices

Date	Close	Volume	Change
02-Jul	$0.44	1,529,528	+0.42 (3,246.15%)
30-Jun	$0.01	23,981,492	0.00 (0.00%)
27-Jun	$0.01	50,567,876	+0.00 (18.18%)
26-Jun	$0.01	30,696,793	0.00 (8.33%)
24-Jun	$0.01	11,610,882	0.00 (7.69%)
23-Jun	$0.01	14,420,312	0.00 (7.14%)
20-Jun	$0.01	20,575,964	+0.00 (7.69%)
19-Jun	$0.01	23,561,700	0.00 (0.00%)
18-Jun	$0.01	24,687,999	0.00 (13.33%)
16-Jun	$0.02	7,454,486	0.00 (0.00%)
13-Jun	$0.02	8,369,714	0.00 (0.00%)
12-Jun	$0.02	5,001,822	0.00 (6.25%)
06-Jun	$0.02	20,099,905	0.00 (0.00%)
05-Jun	$0.02	30,071,038	0.00 (0.00%)
04-Jun	$0.02	25,081,576	+0.00 (14.29%)
4 up, 5 down, and 6 flat days

High $0.10	Low $0.09	Trades 2,797	Turnover $4,713,392	Volume 50,159,971
30 June 2023 at 4:59pm

High $0.10	Low $0.09	Trades 2,797	Turnover $4,713,392	Volume 50,159,971
30 June 2023 at 4:59pm

Imugene Health Care
Cancer Health Care Immunotherapy

$0.091 0.002 (2.25%)

$0.091 0.002 (2.25%)

Followers

Prices

Announcements

Similar Companies

End of Day Prices

Imugene Health Care Cancer Health Care Immunotherapy

$0.091 0.002 (2.25%)

$0.091 0.002 (2.25%)

Followers

Prices

Announcements

Similar Companies

End of Day Prices

Imugene Health Care
Cancer Health Care Immunotherapy